Study of Bortezomib,Lenalidomide,Dexamethasone & Elotuzumab in Newly Diagnosed MM
Clinical trial NCT02375555 · COMPLETED
Trial details
- NCT number
- NCT02375555
- Sponsor
- Dana-Farber Cancer Institute
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-05-07
- Primary completion
- 2021-12-15
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.